Updates on the Molecular Pathology of Selected Ocular and Ocular Adnexal Tumors: Potential Targets for Future Therapy

REFERENCES

• Porter IH, Benedict WF, Brown CD, Paul B. Recent advances in molecular pathology: a review: some aspects of chromosome changes in cancer. Exp Mol Pathol 1969;11:340–367
   PubMed Web of Science ®Google Scholar
• Naber SP. Molecular pathology: detection of neoplasia. N Engl J Med 1994;331:1508–1510
   PubMed Web of Science ®Google Scholar
• Harris TJ, McCormick F. The molecular pathology of cancer. Nat Rev Clin Oncol 2010;7:251–265
   PubMed Web of Science ®Google Scholar
• Dryja TP, Cavenee W, White R, et al. Homozygosity of chromosome 13 in retinoblastoma. N Engl J Med 1984;310:550–553
   PubMed Web of Science ®Google Scholar
• Shields JA, Shields CL. Intraocular Tumors: A Text and Atlas Philadelphia, PA: WB Saunders Company, 1992
   Google Scholar
• Dimaras H, Kimani K, Dimba EA, et al. Retinoblastoma. Lancet 2012; 379:1436–1446
   PubMed Web of Science ®Google Scholar
• Pandey AN. Retinoblastoma: an overview. Saudi J Ophthalmol 2014;28:310–315
   PubMedGoogle Scholar
• Abramson DH, Dunkel IJ, Brodie SE, et al. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery). Ophthalmology 2010;117:1623–1629
   PubMed Web of Science ®Google Scholar
• Grossniklaus HE. Retinoblastoma: fifty years of progress: the LXXI Edward Jackson Memorial Lecture. Am J Ophthalmol 2014;158:875–891
   PubMed Web of Science ®Google Scholar
• Yanoff M, Sassani JW. Ocular Pathology Philadelphia, PA: Mosby Elsevier, 2015
   Google Scholar
• Mendoza PR, Specht CS, Hubbard GB, et al. Histopathologic grading of anaplasia in retinoblastoma. Am J Ophthalmol 2015;159:764–776
   PubMed Web of Science ®Google Scholar
• Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971;68:820–823
   PubMed Web of Science ®Google Scholar
• Friend SH, Bernards R, Rogelj S, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 1986;323:643–646
   PubMed Web of Science ®Google Scholar
• Dunn JM, Phillips RA, Becker AJ, Gallie BL. Identification of germline and somatic mutations affecting the retinoblastoma gene. Science 1988;241:1797–1800
   PubMed Web of Science ®Google Scholar
• Dimaras H, Khetan V, Halliday W, et al. Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet 2008;17:1363–1372
   PubMed Web of Science ®Google Scholar
• Benavente CA, Dyer MA. Genetics and epigenetics of human retinoblastoma. Annu Rev Pathol 2015;10:547–562
   PubMed Web of Science ®Google Scholar
• Harbour JW. Eye cancer: unique insights into oncogenesis: The Cogan Lecture. Invest Ophthalmol Vis Sci 2006;47:1736–1745
   PubMedGoogle Scholar
• Kapatai G, Brundler MA, Jenkinson H, et al. Gene expression profiling identifies different sub-types of retinoblastoma. Br J Cancer 2013;109:512–525
   PubMed Web of Science ®Google Scholar
• Rushlow DE, Mol BM, Kennett JY, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol 2013;14:327–334
   PubMed Web of Science ®Google Scholar
• Lillington DM, Goff LK, Kingston JE, et al. High level amplification of N-MYC is not associated with adverse histology or outcome in primary retinoblastoma tumours. Br J Cancer 2002;87:779–782
   PubMed Web of Science ®Google Scholar
• Eagle RC, Jr. High-risk features and tumor differentiation in retinoblastoma: a retrospective histopathologic study. Arch Pathol Lab Med 2009;133:1203–1209
   PubMed Web of Science ®Google Scholar
• Madhavan J, Ganesh A, Roy J, et al. The relationship between tumor cell differentiation and age at diagnosis in retinoblastoma. J Pediatr Ophthalmol Strabismus 2008;45:22–25
   PubMed Web of Science ®Google Scholar
• Brodeur GM, Seeger RC, Schwab M, et al. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121–1124
   PubMed Web of Science ®Google Scholar
• Kaliki S, Shields CL, Eagle RC Jr, et al. Ciliary body medulloepithelioma: analysis of 41 cases. Ophthalmology 2013;120:2552–2559
   PubMed Web of Science ®Google Scholar
• Broughton WL, Zimmerman LE. A clinicopathologic study of 56 cases of intraocular medulloepitheliomas. Am J Ophthalmol 1978;85:407–418
   PubMed Web of Science ®Google Scholar
• Jakobiec FA, Rose MF, Trief D, Stagner AM, Kim I, Gragoudas ES. Immunohistochemical investigations of adult intraocular medulloepitheliomas. Clin Experiment Ophthalmol 2014;43:379--385
   PubMed Web of Science ®Google Scholar
• Ali MJ, Honavar SG, Vemuganti GK. Ciliary body medulloepithelioma in an adult. Surv Ophthalmol 2013;58:266–272
   PubMed Web of Science ®Google Scholar
• Ramasubramanian A, Correa ZM, Augsburger JJ, et al. Medulloepithelioma in DICER1 syndrome treated with resection. Eye (Lond) 2013;27:896–897
   PubMed Web of Science ®Google Scholar
• Phillips J, Tihan T, Fuller G. Practical molecular pathology and histopathology of embryonal tumors. Surg Pathol Clin 2015;8:73–88
   PubMedGoogle Scholar
• Korshunov A, Sturm D, Ryzhova M, et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 2014;128:279–289
   PubMed Web of Science ®Google Scholar
• Jakobiec FA, Trief D, Rashid A, et al. New insights into the development of infantile intraocular medulloepithelioma. Am J Ophthalmol 2014;158:1275–1296
   PubMed Web of Science ®Google Scholar
• Edward DP, Alkatan H, Rafiq Q, et al. MicroRNA profiling in intraocular medulloepitheliomas. PLoS One 2015;10:e0121706
   Google Scholar
• Durieux E, Descotes F, Nguyen AM, et al. Somatic DICER1 gene mutation in sporadic intraocular medulloepithelioma without pleuropulmonary blastoma syndrome. Hum Pathol 2015;46:783–787
   PubMed Web of Science ®Google Scholar
• Priest JR, Williams GM, Manera R, et al. Ciliary body medulloepithelioma: four cases associated with pleuropulmonary blastoma: a report from the International Pleuropulmonary Blastoma Registry. Br J Ophthalmol 2011;95:1001–1005
   PubMed Web of Science ®Google Scholar
• Korshunov A, Ryzhova M, Jones DT, et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR). Acta Neuropathol 2012;124:875–881
   PubMed Web of Science ®Google Scholar
• Mao XG, Hutt-Cabezas M, Orr BA, et al. LIN28A facilitates the transformation of human neural stem cells and promotes glioblastoma tumorigenesis through a pro-invasive genetic program. Oncotarget 2013;4:1050–1064
   PubMed Web of Science ®Google Scholar
• Jakobiec FA, Kool M, Stagner AM, et al. Intraocular medulloepitheliomas and embryonal tumors with multilayered rosettes of the brain: comparative roles of LIN28A and C19MC. Am J Ophthalmol 2015;159:1065--1074
   PubMed Web of Science ®Google Scholar
• Lv K, Liu L, Wang L, et al. Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One 2012;7:e40008
   PubMed Web of Science ®Google Scholar
• Viswanathan SR, Daley GQ, Gregory RI. Selective blockade of microRNA processing by Lin28. Science 2008;320:97–100
   PubMed Web of Science ®Google Scholar
• Deprez M, Uffer S. Clinicopathological features of eyelid skin tumors: a retrospective study of 5504 cases and review of literature. Am J Dermatopathol 2009;31:256–262
   PubMed Web of Science ®Google Scholar
• Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 2004;111:2151–2157
   PubMed Web of Science ®Google Scholar
• Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five-year follow-up data. Hum Pathol 1982;13:113–122
   PubMed Web of Science ®Google Scholar
• Dasgupta T, Wilson LD, Yu JB. A retrospective review of 1349 cases of sebaceous carcinoma. Cancer 2009;115:158–165
   PubMed Web of Science ®Google Scholar
• Nelson BR, Hamlet KR, Gillard M, et al. Sebaceous carcinoma. J Am Acad Dermatol 1995;33:1–15
   PubMed Web of Science ®Google Scholar
• Shields JA, Demirci H, Marr BP, et al. Sebaceous carcinoma of the ocular region: a review. Surv Ophthalmol 2005;50:103–122
   PubMed Web of Science ®Google Scholar
• Jakobiec FA, Mendoza PR. Eyelid sebaceous carcinoma: clinicopathologic and multiparametric immunohistochemical analysis that includes adipophilin. Am J Ophthalmol 2014;157:186–208
   PubMed Web of Science ®Google Scholar
• Jakobiec FA, Werdich X. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas. Am J Ophthalmol 2014;157:687–696
   PubMed Web of Science ®Google Scholar
• Larrea AA, Lujan SA, Kunkel TA. SnapShot: DNA mismatch repair. Cell 2010;141:730
   PubMedGoogle Scholar
• Shalin SC, Lyle S, Calonje E, Lazar AJ. Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications. Histopathology 2010;56:133–147
   PubMed Web of Science ®Google Scholar
• Entius MM, Keller JJ, Drillenburg P, et al. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome. Clin Cancer Res 2000;6:1784–1789
   PubMed Web of Science ®Google Scholar
• Singh RS, Grayson W, Redston M, et al. Site and tumor type predicts DNA mismatch repair status in cutaneous sebaceous neoplasia. Am J Surg Pathol 2008;32:936–942
   PubMedGoogle Scholar
• Abbas O, Mahalingam M. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm. J Cutan Pathol 2009;36:613–619
   PubMed Web of Science ®Google Scholar
• Gaskin BJ, Fernando BS, Sullivan CA, et al. The significance of DNA mismatch repair genes in the diagnosis and management of periocular sebaceous cell carcinoma and Muir-Torre syndrome. Br J Ophthalmol 2011;95:1686–1690
   PubMed Web of Science ®Google Scholar
• Kwon MJ, Shin HS, Nam ES, et al. Comparison of HER2 gene amplification and KRAS alteration in eyelid sebaceous carcinomas with that in other eyelid tumors. Pathol Res Pract 2015 May;211:349–355
   PubMed Web of Science ®Google Scholar
• Eiermann W. Trastuzumab combined with chemotherapy for the treatment of HER2-positive metastatic breast cancer: pivotal trial data. Ann Oncol 2001;12(Suppl 1):S57–62
   PubMed Web of Science ®Google Scholar
• Cho KJ, Khang SK, Koh JS, et al. Sebaceous carcinoma of the eyelids: frequent expression of c-erbB-2 oncoprotein. J Korean Med Sci 2000;15:545–550
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar Dorairaj S, Prabhakaran VC, et al. Identification of genes associated with tumorigenesis of meibomian cell carcinoma by microarray analysis. Genomics 2007;90:559–566
   PubMed Web of Science ®Google Scholar
• Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15–16
   PubMed Web of Science ®Google Scholar
• Scheffner M, Werness BA, Huibregtse JM, et al. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129–1136
   PubMed Web of Science ®Google Scholar
• Hayashi N, Furihata M, Ohtsuki Y, Ueno H. Search for accumulation of p53 protein and detection of human papillomavirus genomes in sebaceous gland carcinoma of the eyelid. Virchows Arch 1994;424:503–509
   PubMed Web of Science ®Google Scholar
• Gonzalez-Fernandez F, Kaltreider SA, Patnaik BD, et al. Sebaceous carcinoma: tumor progression through mutational inactivation of p53. Ophthalmology 1998;105:497–506
   PubMed Web of Science ®Google Scholar
• Kiyosaki K, Nakada C, Hijiya N, et al. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest Ophthalmol Vis Sci 2010;51:7–11
   PubMed Web of Science ®Google Scholar